Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases
Andrew Mendiola, PhD named 2020 Berkelhammer Scholar
Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease
Illustration of amyloid plaques on a nerverticale cell.
MS researcher gets it in gear
Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society
Toxic Cell Atlas Guides New Therapies for Neurodegeneration
Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.
Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.
